Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ

Clinical trial NCT06414499 · RECRUITING

Trial details

NCT number: NCT06414499
Sponsor: Beijing Tiantan Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Minor Ischemic Stroke

Start date: 2025-07-09
Primary completion: 2026-07-31
Enrollment: 1386

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.